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Rapamycin, a potent immunosuppressive drug that 
disrupts normal signal-transduction processes, in-
hibited hepatocyte proliferation without evidence of 
inherent cytotoxicity in rat hepatocytes cultured in 
conventional medium or in a medium enriched with 
epidermal growth factor. The antiproliferative effect 
was dose dependent, uninfluenced by the concen-
tration of epidermal growth factor in the medium and 
long lasting after a brief exposure. The effect of ra-
pamycin was unaltered by the concomitant presence of 
FK 506 in the medium, suggesting that different 
binding affinities of these two drugs or even a separate 
rapamycin binding site may exist. Hepatocytes har-
vested 12 and 24 hr after partial hepatectomy were 
progressively less responsive to the antiproliferative 
effect of rapamycin. The gene expression of trans-
forming growth factor-~ was reduced under in vivo 
rapamycin treatment, but at the same time the gene 
expression of albumin and glyceraldehyde-3-phos-
phate dehydrogenase was unchanged or increased. The 
experiments confirm that rapamycin has inherent 
growth-control qualities, and they strengthen the hy-
pothesis that the recently defined immunophilin 
network is central to many aspects of cellular growth 
control. (HEPATOLOGY 1992;15:871-877.) 
In both rats and dogs, the immunosuppressive drugs 
cyclosporine (CYA) and FK506 augment liver regener-
ation (1-4) and possess other hepatotrophic qualities (5, 
6). In contrast, rapamycin (RPM), a powerful immuno-
suppressant that is chemically related to FK 506 but 
targeted to a different stage of T-cell activation (7, 8), 
was recently shown to have antiproliferative properties, 
including inhibition of regeneration of the liver and of 
the intestine and kidney (9). We report here studies on 
the antiproliferative action of RPM on cultured rat 
hepatocytes in conventional medium, on hepatocytes in 
epidermal growth factor (EGF)-enriched medium and 
on hepatocytes harvested at different phases of the 
regeneration response. We also describe a selective 
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reduction by RPM on the gene expression of trans-
forming growth factor-~ Eqdc-~FK The expression of 
albumin and glyceraldehyde-3-phosphate dehydro-
genase (GAP) genes was unaltered or increased. 
MATERIALS AND METHODS 
Animals. Hepatocytes for culture were harvested from 
regenerating or nonregenerating livers of male Fischer F344 
rats weighing between 180 and 200 gm (Hilltop Lab Animals, 
Inc., Scottdale, PA). Seventy-percent hepatectomy was per-
formed as described by Higgins and Anderson (10). The 
animals were housed in a temperature- and light (6 AM to 6 
pM)-controlled room and received food and water ad libitum. 
All surgical procedures were performed between 8 and 10 AM. 
Injections were made intraperitoneally. 
Materials. Collagenase (type 1) (140 to 170 units/mg) was 
purchased from Worthington Diagnostic Systems (Freehold 
NJ). Eagles' MEM and FCS were purchased from GIBCd 
Laboratories (Grand Island, NY); insulin, HEPES and pyruvic 
acid were from Sigma Chemical Co. (St. Louis, MO). EGF was 
from Collaborative Research, Inc. (Bedford, MA); [methyl-
3H]thymidine (50 to 80 Ci/mmol) was from Du Pont-New 
England Nuclear (Boston, MA). Gentamicin was from Elkins-
Sinn, Inc. (Cherry Hill, NJ); and scintillant (Aquasol) was from 
Anlersham Corp. (Arlington Heights, IL). RPM was a gift from 
Dr. Joseph Chang (Wyeth-Ayerst Research, Princeton, NJ). 
FK 506 was a gift from Fujisawa Pharmaceutical Company 
Ltd. (Osaka, Japan). CYA was a gift from Sandoz Pharmaceu-
ticals, Inc. (East Hanover, NJ). 
Hepatocytes in Primary Culture 
Livers were removed from previously unaltered 7 -wk-old 
male rats weighing between 180 and 200 gm or 12 to 24 hr after 
70% hepatectomy in some of these animals. Hepatocytes were 
isolated by a modification (11) of the in situ two-step 
collagenase perfusion technique of Seglen (12) modified by 
Jirtle et al. (13). The hepatocytes were dispersed and washed 
twice with cold Ca + + -free perfusion buffer and resuspended 
in basal medium (MEM) supplemented with pyruvate 
(1 mmoVL), proline (0.26 mmoVL), insulin (10- 7 moVL) and 
5% FCS. Viability was determined by trypan blue exclusion, 
and only preparations with viability greater than 90% at the 
outset were used. Cell number was determined with a 
hemocytometer. 
The cells were plated at a cell density of 6.5 x 104/well in a 
Corning 35-mm tissue culture dish (Corning, Inc., Corning, 
NY) containing 1.5 ml medium and maintained at 37° C in a 5% 
CO2 atmosphere. After a 3-hr attachment period the medium 
was aspirated, and 1.5 ml MEM with 5% normal rat serum was 
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TABLE 1. Viability, DNA concentration and transaminase levels of hepatocytes cultured in serum-free medium 
containing RPM 
24 hr 48 hr 
Viability DNA Viability DNA ALT 
RPM dose percentage (",gldish) percentage (",gldish) (U/mI) 
Control 95 ± 4a 3.2 ± 0.2 96 ± 3 3.3 ± 0.2 10 ± 2 
RPM 
0.4 ng/ml 94 ± 3 3.3 ± 0.3 96 ± 4 3.3 ± 0.2 11 ± 4 
4 ng/ml 96 ± 4 3.2 ± 0.3 95 ± 5 3.2 ± 0.3 10 ± 3 
10 ng/ml 94 ± 3 3.3 ± 0.3 97 ± 3 3.3 ± 0.2 11 ± 2 
GData expressed as the average from nine dishes and three different animals (mean ± S.D.). 
TABLE 2. DNA concentration and labeling index of 
hepatocytes cultured in the presence of different 
concentrations of RPM 
RPM dose DNA (",gldish) Labeled nuclei (%) 
Control 6.1 + l.3a 10 + 1.5 
RPM 
10 ng/ml 3.3 + 0.2b 5.8 + 0.9c 
2.5 ng/ml 3.3 + O.4b 6.1 + 0.8b 
1 ng/ml 3.7 + 0.3b 6.5 + 0.6b 
0.25 ng/ml 4.2 + 0.35 7.1 + 0.8 
aData are average from six dishes for each RPM concentration. 
Medium was enriched with 5% normal rat serum. 
bp < 0.05 vs. control. 
c p < 0.01 vs. control. 
added to maintain RPM in solution. EGF and insulin were 
present in concentrations of 10 ng/ml and 10 -7 mol/L, 
respectively. RPM, FK 506 and CYA were dissolved in alcohol 
and added in the appropriate concentrations. The amount of 
alcohol added to the medium was 1 !-LI/ml; it did not affect 
hepatocyte proliferation. 
In Vitro [3Hlthymidine Incorporation. To determine in 
vitro DNA synthesis, 3 !-LCi [3H]thymidine was added to each 
well and maintained from 24 to 48 hr of the culture period. 
When the cells were harvested, DNA content was determined 
by the microfluorometric method of Setara and Morley (14), 
and DNA synthesis was measured by the method of Michalo-
poulos et al. (15). 
Autoradiography. For autoradiographic studies, hepato-
cytes were plated in 35-mm dishes as previously described (11, 
16). [3H]thymidine, 7.5 !-LCi/dish, was present for 24 hr before 
fixation. Fixed cells in the dishes were covered with emulsion 
(Kodak NTB3), and the dishes were developed after 10 days. 
The labeling index was determined by counting a total of 1,000 
cellsfdish. 
Gene-expression Studies. Total cellular RNA from rat livers 
or from primary cultures of rat hepatocytes was extracted by 
RNAzol using the manufacturer's procedure (Biotecx, 
Houston, TX). Total RNA (20 /Lg) was subjected to electro-
phoresis in a 1% agarose gel in 10 mmol/L Na3 P04 with 
constant recirculation. The fractionated RNA was transferred 
to Zitabind nylon membrane (Whatman, Maidstone, UK) 
overnight in 20 x standard saline citrate. After transfer, the 
blot was fixed by UV light (short wave, 254 nm). cDNA probes 
were labeled with 32p with a random-primed labeling kit 
(Boehringer, Indianapolis, IN). Prehybridization was per-
formed at 70° C for 30 min to 3 hr with Church buffer (1 % BSA, 
7% SDS, 0.5 mol/L sodium phosphate, 1 mmol/L EDTA); then 
32 P-Iabeled, denatured probes in Church buffer were added at 
70° C for hybridization (17). After hybridization, the mem-
branes were washed twice in buffer A (1% BSA, 5% SDS, 40 
mmol/L sodium phosphate and 1 mmol/L EDTA), at 70° C for 
20 min and then washed in buffer B (1% SDS, 40 mmol/L 
sodium phosphate and 1 mmol/L EDT A) at 70° C for 20 min 
(four times). The washed, air-dried membranes were autora-
diographed at - 70° C. To check for equivalent transfer of 
RNAs from agarose gel to membrane, the gel was stained with 
ethidium bromide after capillary transfer; little RNA was 
found to remain in any lane. Before probe hybridization, the 
membranes were checked in UV light; similar amounts of RNA 
were found to have been transferred to each lane. The probes 
used were qdc-~l (gift from R. Derynk; Genentech, San 
Francisco, CA), rat albumin (gift from T. Sargent, NIH) and 
glyceraldehyde-3-phosphate dehydrogenase (GAP) (gift of Dr. 
S. Thorgeirsson, NIH). For FK binding proteinfRPM binding 
protein gene transcripts, RNA was reverse-transcribed by 
oligonucleotide primers (primers from R. F. Standaert and S. 
L. Schreiber, Department of Chemistry, Harvard University, 
[18]), and the resulting complementary DNA was amplified by 
PCR. The products were subjected to electrophoresis on a 2% 
agarose gel with molecular weight markers. 
Other Methods and Statistical Analysis 
Proteins were determined by the method of Lowry et al. (19). 
An unpaired, one-tailed Student's t test was used for statistical 
analysis of the data. 
RESULTS 
Hepatocytes From Resting Liver 
Hepatocyte Viability in Resting Liver. More than 95% 
of the control hepatocytes were alive 24 and 48 hr after 
the 3-hr attachment period, a viability that was not 
affected by any dose of RPM. Nor were there changes in 
the hepatocyte DNA content or AL T concentration in 
the culture medium (Table 1). 
Hepatocyte Proliferation. DNA synthesis was de-
pressed by RPM in a dose-related manner, an effect not 
seen with FK 506 or CYA (Fig. 1, bottom). 
Comparable results were obtained with higher-
baseline DNA synthesis, which occurs after enrichment 
of the medium with EGF (Fig. 1, top). The results with 
RPM were confirmed by autoradiography (Table 2). For 
any given dose of RPM, the degree of DNA synthesis 
depression was similar no matter what the amount of 
EGF added to the medium between 10 and 40 ng/ml 
(Fig. 2). In experiments in which washing and medium 
change terminated the briefer exposures to RPM, the 
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FIG. 1. Effect of different doses of FK 506, CYA and RPM on DNA 
synthesis in hepatocytes cultured in the presence (top) or absence 
(bottom) ofEGF. FK506 and eYA were previously shown to be inactive 
in the system at 10 times the maximum doses used for these 
experiments (24). n = 9 for all data points, which represent three 
experiments with triplicate determinations. Data expressed as 
mean ± S.D. 
inhibitory effect of RPM was the same whether contact 
with RPM was for the entire 48 hr of culture or for 
intervals as short as the first 3 hr (Fig. 3). 
The inhibitory effect of RPM was not changed by 
adding FK 506, even with FK 506 doses approximately 
4,000 times greater than those of RPM (Fig. 4). 
Hepatocytes From Regenerating Liver 
Hepatocytes harvested 12 and 24 hr after 70% 
hepatectomy and cultured in EGF-enriched medium 
were responsive to RPM inhibition but far less so than 
hepatocytes from normal rats (Fig. 5). RPM resistance 
was more pronounced in hepatocytes from rats 24 hr 
after partial hepatectomy than in those harvested 12 hr 
after hepatectomy. Inhibition of DNA synthesis could be 
seen only with the highest RMP dose of 5 ng/ml. 
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FIG. 2. Effect of different doses of EGF on hepatocyte proliferation 
in the presence of different concentrations of RPM. n = 9 for all data 
points. Data expressed as mean ± S.D. 
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FIG. 3. Effect of the time of RPM exposure on hepatocyte 
proliferation in medium enriched with 10 ng/ml EGF. The dish 
contained 5 ng/ml RPM at zero time; at the end of RPM exposure, the 
medium was removed and after three washes was replaced with 
RPM-free medium. n = 9 for all data points. Data expressed as 
mean ± S.D. 
The relative resistance to the inhibitory effects of 
RPM by hepatocytes from regenerating liver compared 
with hepatocytes from normal liver could be due to 
differences in the ability to bind RPM because both FK 
506 and RPM have been reported to bind to FK/RPM 
binding protein (FKBP). This possibility was weakened 
by the absence of any substantial decrease in the 
messenger RNA amounts for FKBP in hepatocytes from 
regenerating liver compared with resting liver (Fig. 6). A 
small increase in FKBP mRNA is shown in the gel in 
hepatocytes from regenerating liver. We think that this 
is not significant, since various dilutions of resting and 
regenerating hepatocyte RNA's (data not shown) re-
vealed essentially no differences in FKBP mRNA 
amounts. 
Changes in Gene Expression In Vivo 
Two rats each were treated for 5, 4, 3, 2, and 1 day 
with 0.1 mg/kg/day rapamycin intramuscularly and 
killed for RNA extraction. The TGF-f3 mRNA, which 
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FIG. 6. Expression of FKBP mRNA by reverse-transcription 
polymerase chain reaction. Lanes a and b are hepatocytes from normal 
liver; lanes c and d are hepatocytes from regenerating liver; lane e 
shows molecular-weight markers. 
normally is found in low levels in resting liver, was 
suppressed completely after 4 days of therapy (Fig. 7) in 
resting rats. The mRNA levels of the two nongrowth 
genes, albumin (Fig. 8) and GAP (Fig. 9), had different 
changes. Albumin mRNA initially showed a slight 
decrease but then increased again . GAP mRNA actually 
increased at the time of minimum TGF-f3 mRNA 
expression. 
Two additional rats underwent 70% hepatectomy 
after 5 days of RPM treatment. The TGF-f3 mRNA tran-
scripts failed to increase after the partial hepatectomy 
(lanes a and b, Fig. 10), in contrast to the sharp increase 
in two saline solution-treated hepatectomy controls. 
DISCUSSION 
The immunosuppression ofCYA, FK 506 and RPM is 
caused by variable modification of signal transduction in 
immune cells (7, 8, 20). CYA and FK 506 inhibit the 
transcription of early T-cell activation genes, including 
interleukin-2 (21, 22), whereas RPM blocks downstream 
events resulting from T-cell activation (7, 8). The reason 
for this difference in drug action is not known. The 
binding sites of CYA (cyclophilin) and FK 506 (FImP) 
are different low-molecular-weight proteins (23, 24). 
Although RPM was initially thought to bind to 
FKBP, recent genetic evidence in yeast experiments 
has suggested that a separate binding protein (RBP) 
closely related to FImP may also exist (25). The 
demonstration herein reported of an absence of com-
petitive action in our in vitro growth-control system 
is compatible with this possibility but does not prove 
it. Other unpublished observations are consistent with 
the existence of a binding protein with a different 
molecular weight and binding affinity than FImP. 
In the Harvard laboratories (Albers MW et al., 
Unpublished observation, 1991), a 30-kD protein 
called FKBP :'l0' which has a sequence related to that 
of the original FKBP (called FImP 12) has been 
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FIG. 7. Northern blot of TGF-13 1 mRNA levels from livers of resting rats treated with RPM for 0, 1, 2, 3, 4 or 5 days. 
shown to bind RPM more than 100 times more selec-
tively than FK 506. 
Collectively, these ubiquitous binding proteins-
which have in common enzyme peptidyl-prolyl 
isomerase (PPIase) activity (23, 24)-have been concep-
tualized as an immunophilin network with potential 
pleiotropic activities not limited to those affecting the 
immune system (6,18,26). Whether PPIase is central to 
the function of the immunophilin system or merely a 
marker of it is unresolved. 
The possibility that CYA, FK 506 or both alter 
immunologically independent signaling pathways that 
affect growth was raised by in vivo experiments in rats 
and dogs showing that both drugs augment liver 
regeneration and have other hepatotrophic actions (6, 
24). Further experiments showed that this augmen-
tation was not related to T-cell or natural killer cell 
deficiency (27). The demonstration in intact rats of an 
opposite (antiproliferative) effect of RPM with reduction 
or abolition of liver, kidney and intestinal regeneration 
was of unusual interest because it was the first example 
of down-regulation by a drug of this physiological 
manifestation of the immunophilin system (9). 
The in vitro observations reported herein support our 
previous conclusion from in vivo experiments that RPM 
is a growth inhibitor (9). The ease with which growth 
regulation by RPM could be detected in hepatocyte 
cultures was in contrast to the previous difficulty of 
demonstrating the stimulation of isolated hepatocytes 
either by CYA or FK 506 (28), which had been 
anticipated from the results of in vivo experiments with 
these drugs. Immune modulation as the primary expla-
nation of the RPM effect was greatly weakened in our 
current experiments because more than 99% of the cells 
in our cultures have been shown to be hepatocytes with 
liver-specific enzymes (11, 15). However, because the 
cells were plated in 5% FCS and grown in 5% normal 
serum, it can not be excluded that RPM prevented the 
trophic action of a factor(s) released into the sera by 
immunocytes. The RPM inhibition of proliferation of 
either resting hepatocytes or EGF-driven hepatocytes 
was unambiguously demonstrated over a wide dose 
range. 
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FIG. 8. Northern blot of rat albumin mRNA levels. RNA samples are 
identical to those of Figure 7. 
Brief exposure to RPM had as profound an effect on 
nonregenerating hepatocytes during the succeeding 2 
days as continuous exposure for the same period. 
Proliferation was harder to suppress in cultured hepa-
tocytes committed to regeneration by prior partial 
hepatectomy, but even 24 hr after hepatectomy these 
hepatocytes (which were at the peak of the regeneration 
response) could be partially inhibited with high RPM 
doses. Growth inhibition was not due to inherent 
hepatotoxicity because cell viability was not jeopardized 
in the conditions of our culture model over the full 48-hr 
testing period. In addition, the gene expression of 
albumin and GAP were unaltered or actually enhanced. 
Further investigations will be required to establish 
the molecular basis for the growth-regulatory qualities 
of these immunosuppressive drugs and their interac-
tions with other putative growth factors. Our finding of 
a profound decrease in the expression of TGF -13, but not 
in that of non-growth-associated genes such as albumin 
or GAP, suggests that the inhibitory actions of RPM on 
liver growth are intricately associated with liver-growth 
gene expression, although the mechanism of this effect 
is not clear. 
TGF-!3 is a potent bifunctional growth-regulating 
peptide that can stimulate fibroblast growth, but in-
hibits the growth of most epithelial cells, including 
hepatocytes in vitro and in vivo (17, 29, 30). We postulate 
that the action of an externally administered inhibitor of 
growth, such as RPM, may alter the requirement for an 
endogenous putative inhibitor, such as TGF-!3, and 
might explain our findings and constitute an example of 
intracellular homeostasis at the level of gene expression. 
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FIG. 9. Northern blot of GAP mRNA levels. RNA samples are identical to those of Figure 7. 
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FIG. 10. Northern blot of TGF-131 mRNA levels from livers after 
partial hepatectomy (48 hr) treated without (lane a) or with (lane b) 
RPM. Lane c is RNA from nonparenchymal liver cells (positive 
control). 
It now seems possible that the alterations in signal 
transduction that have been caused in immune cells by 
FK 506 and other drugs may play an analogous role in 
nonimmunologic functions subserved by the immuno-
philin network. The possibility that biologically active 
complexes are formed by ligands and the cytosolic 
binding proteins has been suggested by the recent 
demonstration that recombinant FKBP has physiologic 
growth control activity in vivo (31), presumably after 
binding with endogenous ligands in these drug-free 
dogs. Other evidence comes from genetic studies in 
Saccharomyces cerevisiae that demonstrate that, for 
example, the complexes of yeast FKBP and RPM or 
human FKBP and RPM are responsible for mediating 
the antibiotic actions of RPM in yeast (25). 
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